Bain Capital Life Sciences Investors, LLC

13F Filings History

Latest 13F report
Q3 2024 - Nov 14, 2024
Value $
$961M
Signature - Title
Adam Koppel - Partner of Bain Capital Life Sciences Investors, LLC
Location
Boston, MA
Summary
This page shows a list of all the recent 13F filings made by Bain Capital Life Sciences Investors, LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Bain Capital Life Sciences Investors, LLC reported 24 stock holdings with total value $961M as of Q3 2024. Top holdings included NUVL, NAMS, IRON, DNTH, and SVRA.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q3 2024 24 $961M +$14.2M -$12.1M +$2.09M NUVL, NAMS, IRON, DNTH, SVRA 13F-HR 11/14/2024, 07:01 AM
Q2 2024 25 $911M +$39.6M -$82M -$42.3M NUVL, NAMS, IRON, DNTH, PHVS 13F-HR 8/12/2024, 01:30 PM
Q1 2024 26 $1.24B +$187M -$210M -$23.1M NAMS, NUVL, DNTH, IRON, KYTX 13F-HR 5/15/2024, 01:00 PM
Q4 2023 27 $1.04B +$124M -$202M -$78.9M NUVL, NAMS, PHVS, IRON, MDGL 13F-HR 2/13/2024, 04:30 PM
Q3 2023 31 $894M +$20.8M -$82.8M -$62M NUVL, PHVS, NAMS, SWTX, IRON 13F-HR 11/14/2023, 04:00 PM
Q2 2023 32 $971M +$87.4M -$74.6M +$12.8M NUVL, NAMS, SWTX, PHVS, IRON 13F-HR 8/14/2023, 04:31 PM
Q1 2023 34 $800M +$95.4M -$125M -$30M NAMS, NUVL, SWTX, IRON, NTRA 13F-HR 5/15/2023, 04:12 PM
Q4 2022 33 $895M +$210M -$66.2M +$144M SWTX, NUVL, NAMS, NTRA, MRSN 13F-HR 2/14/2023, 07:27 AM
Q3 2022 33 $838M +$58.4M -$84.9M -$26.6M SWTX, NUVL, MRSN, ARQT, DVAX 13F-HR 11/14/2022, 04:00 PM
Q2 2022 35 $853M +$73.6M -$43.3M +$30.3M SWTX, DVAX, PHVS, ARQT, EQRX 13F-HR 8/15/2022, 04:02 PM
Q1 2022 34 $1.03B +$61.2M -$5.38M +$55.8M SWTX, DVAX, ARQT, PHVS, RPID 13F-HR 5/16/2022, 04:01 PM
Q4 2021 34 $1.26B +$141M -$79.4M +$62M SWTX, DVAX, RPID, ARQT, EQRX 13F-HR 2/14/2022, 08:31 AM
Q3 2021 33 $1.6B +$369M -$229M +$140M SWTX, DVAX, RPID, AVIR, IVVD 13F-HR 11/15/2021, 04:08 PM
Q2 2021 30 $1.53B +$50.1M -$57M -$6.93M SWTX, AVIR, DVAX, DRNA, ARQT 13F-HR 8/16/2021, 04:23 PM
Q1 2021 31 $1.77B +$282M -$173M +$110M SWTX, AVIR, ARQT, DVAX, ANNX 13F-HR 5/17/2021, 06:58 AM
Q4 2020 26 $1.59B +$450M -$169M +$282M SWTX, AVIR, ARQT, MRSN, ANNX 13F-HR 2/16/2021, 06:13 AM
Q3 2020 22 $1.05B +$202M -$56.1M +$146M SWTX, ARQT, ANNX, DRNA, MRSN 13F-HR 11/16/2020, 08:10 AM
Q2 2020 15 $932M +$164M -$41.5M +$123M SWTX, ARQT, DRNA, DVAX, MRSN 13F-HR 8/14/2020, 08:05 AM
Q1 2020 11 $568M +$127M -$19.5M +$107M SWTX, ARQT, DRNA, CNST, DVAX 13F-HR 5/15/2020, 08:00 AM
Q4 2019 10 $671M +$176M -$71.6M +$104M SWTX, CNST, DRNA, DVAX, REPL 13F-HR 2/14/2020, 08:08 AM
Q3 2019 7 $388M +$208M $0 +$208M SWTX, DRNA, SLDB, REPL, DVAX 13F-HR 11/14/2019, 08:32 AM
Q2 2019 5 $197M $0 -$52.9M -$52.9M DRNA, REPL, MRNS, SLDB, APTX 13F-HR 8/14/2019, 09:01 AM
Q1 2019 6 $250M $0 -$39M -$39M DRNA, REPL, IFRX, MRNS, SLDB 13F-HR 5/15/2019, 09:01 AM
Q4 2018 6 $293M +$3.06M $0 +$3.06M DRNA, IFRX, SLDB, APTX, REPL 13F-HR 2/14/2019, 08:30 AM
Q3 2018 6 $441M +$45.7M $0 +$45.7M DRNA, SLDB, APTX, IFRX, REPL 13F-HR 11/14/2018, 06:42 AM
Q2 2018 5 $0 $0 $0 13F-HR 8/14/2018, 07:12 AM
Q1 2018 4 $170M +$14.9M $0 +$14.9M DRNA, IFRX, MRNS, SLDB 13F-HR 5/15/2018, 07:28 AM
Q4 2017 3 $152M $0 $0 DRNA, IFRX, MRNS 13F-HR 2/14/2018, 07:21 AM